Your browser doesn't support javascript.
loading
SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contexts.
Kroemer, Marie; Spehner, Laurie; Mercier-Letondal, Patricia; Boullerot, Laura; Kim, Stefano; Jary, Marine; Galaine, Jeanne; Picard, Emilie; Ferrand, Christophe; Nguyen, Thierry; Larosa, Fabrice; Adotévi, Olivier; Godet, Yann; Borg, Christophe.
Afiliação
  • Kroemer M; University of Bourgogne Franche-Comté (UBFC), INSERM, EFS BFC, UMR1098, Interactions hôte-greffon-tumeur - Ingénierie Cellulaire et Génique, Besançon, France.
  • Spehner L; Department of pharmacy, University hospital of Besançon, Besançon, France.
  • Mercier-Letondal P; University of Bourgogne Franche-Comté (UBFC), INSERM, EFS BFC, UMR1098, Interactions hôte-greffon-tumeur - Ingénierie Cellulaire et Génique, Besançon, France.
  • Boullerot L; University of Bourgogne Franche-Comté (UBFC), INSERM, EFS BFC, UMR1098, Interactions hôte-greffon-tumeur - Ingénierie Cellulaire et Génique, Besançon, France.
  • Kim S; University of Bourgogne Franche-Comté (UBFC), INSERM, EFS BFC, UMR1098, Interactions hôte-greffon-tumeur - Ingénierie Cellulaire et Génique, Besançon, France.
  • Jary M; Department of medical oncology, University Hospital of Besançon, Besançon, France.
  • Galaine J; University of Bourgogne Franche-Comté (UBFC), INSERM, EFS BFC, UMR1098, Interactions hôte-greffon-tumeur - Ingénierie Cellulaire et Génique, Besançon, France.
  • Picard E; Department of medical oncology, University Hospital of Besançon, Besançon, France.
  • Ferrand C; University of Bourgogne Franche-Comté (UBFC), INSERM, EFS BFC, UMR1098, Interactions hôte-greffon-tumeur - Ingénierie Cellulaire et Génique, Besançon, France.
  • Nguyen T; University of Bourgogne Franche-Comté (UBFC), INSERM, EFS BFC, UMR1098, Interactions hôte-greffon-tumeur - Ingénierie Cellulaire et Génique, Besançon, France.
  • Larosa F; University of Bourgogne Franche-Comté (UBFC), INSERM, EFS BFC, UMR1098, Interactions hôte-greffon-tumeur - Ingénierie Cellulaire et Génique, Besançon, France.
  • Adotévi O; Department of medical oncology, University Hospital of Besançon, Besançon, France.
  • Godet Y; Department of hematology, University Hospital of Besançon, Besançon, France.
  • Borg C; University of Bourgogne Franche-Comté (UBFC), INSERM, EFS BFC, UMR1098, Interactions hôte-greffon-tumeur - Ingénierie Cellulaire et Génique, Besançon, France.
Oncoimmunology ; 7(4): e1412030, 2018.
Article em En | MEDLINE | ID: mdl-29632725
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncoimmunology Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncoimmunology Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França